Trial Profile
How does proton pump inhibitor [esomeprazole] therapy impact quality of life in patients newly diagnosed with erosive reflux esophagitis?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2010
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Erosive oesophagitis
- Focus Therapeutic Use
- 07 May 2010 Actual patient number (65) added as reported by ClinicalTrials.gov.
- 26 Aug 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 26 Aug 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.